Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 3.77
(3.86%)
CNY 3.77
(3.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.98 Million CNY | -406.44% |
| 2022 | -5.92 Million CNY | -100.19% |
| 2021 | 3.12 Billion CNY | 856.89% |
| 2020 | 326.22 Million CNY | 70.71% |
| 2019 | 191.09 Million CNY | 327.73% |
| 2018 | -83.91 Million CNY | -123.22% |
| 2017 | 361.33 Million CNY | 74.3% |
| 2016 | 207.3 Million CNY | 384.11% |
| 2015 | 42.82 Million CNY | 82.33% |
| 2014 | 23.48 Million CNY | -71.33% |
| 2013 | 81.92 Million CNY | -2.8% |
| 2012 | 84.28 Million CNY | -28.97% |
| 2011 | 118.66 Million CNY | 13.09% |
| 2010 | 104.92 Million CNY | 27.45% |
| 2009 | 82.32 Million CNY | 11.94% |
| 2008 | 73.54 Million CNY | 30.47% |
| 2007 | 56.37 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 32.28 Million CNY | 177.39% |
| 2024 Q2 | 12.13 Million CNY | -62.42% |
| 2024 Q3 | 12.63 Million CNY | 4.12% |
| 2023 Q3 | -16.84 Million CNY | -179.17% |
| 2023 Q2 | 21.27 Million CNY | 191.31% |
| 2023 Q4 | -41.72 Million CNY | -147.68% |
| 2023 Q1 | 7.3 Million CNY | 109.77% |
| 2023 FY | -29.98 Million CNY | -406.44% |
| 2022 Q1 | 18.06 Million CNY | -99.34% |
| 2022 Q2 | 39.86 Million CNY | 120.65% |
| 2022 FY | -5.92 Million CNY | -100.19% |
| 2022 Q4 | -74.75 Million CNY | -785.48% |
| 2022 Q3 | 10.9 Million CNY | -72.64% |
| 2021 Q1 | 117.5 Million CNY | -7.92% |
| 2021 Q3 | 113.28 Million CNY | -28.73% |
| 2021 FY | 3.12 Billion CNY | 856.89% |
| 2021 Q4 | 2.73 Billion CNY | 2311.44% |
| 2021 Q2 | 158.95 Million CNY | 35.28% |
| 2020 FY | 326.22 Million CNY | 70.71% |
| 2020 Q2 | 27.25 Million CNY | -62.92% |
| 2020 Q1 | 73.51 Million CNY | 277.22% |
| 2020 Q3 | 97.83 Million CNY | 258.91% |
| 2020 Q4 | 127.61 Million CNY | 30.44% |
| 2019 Q1 | 63.42 Million CNY | 133.13% |
| 2019 FY | 191.09 Million CNY | 327.73% |
| 2019 Q4 | 19.48 Million CNY | -56.25% |
| 2019 Q3 | 44.54 Million CNY | -30.01% |
| 2019 Q2 | 63.64 Million CNY | 0.35% |
| 2018 Q3 | -17.66 Million CNY | -128.01% |
| 2018 Q1 | 62.1 Million CNY | -40.87% |
| 2018 Q4 | -191.42 Million CNY | -983.37% |
| 2018 Q2 | 63.07 Million CNY | 1.57% |
| 2018 FY | -83.91 Million CNY | -123.22% |
| 2017 Q4 | 105.02 Million CNY | 30.45% |
| 2017 Q2 | 110.81 Million CNY | 70.53% |
| 2017 FY | 361.33 Million CNY | 74.3% |
| 2017 Q1 | 64.98 Million CNY | -40.91% |
| 2017 Q3 | 80.51 Million CNY | -27.34% |
| 2016 Q4 | 109.96 Million CNY | 53.71% |
| 2016 Q1 | 13.08 Million CNY | 329.73% |
| 2016 FY | 207.3 Million CNY | 384.11% |
| 2016 Q2 | 13.21 Million CNY | 0.97% |
| 2016 Q3 | 71.53 Million CNY | 441.41% |
| 2015 Q2 | 12.66 Million CNY | 18.06% |
| 2015 FY | 42.82 Million CNY | 82.33% |
| 2015 Q4 | 3.04 Million CNY | -81.42% |
| 2015 Q3 | 16.39 Million CNY | 29.46% |
| 2015 Q1 | 10.72 Million CNY | 609.75% |
| 2014 Q2 | -794.92 Thousand CNY | -104.69% |
| 2014 Q4 | -2.1 Million CNY | -122.26% |
| 2014 Q3 | 9.45 Million CNY | 1289.1% |
| 2014 FY | 23.48 Million CNY | -71.33% |
| 2014 Q1 | 16.93 Million CNY | 2.36% |
| 2013 Q2 | 13.76 Million CNY | -50.41% |
| 2013 Q3 | 23.86 Million CNY | 73.34% |
| 2013 Q4 | 16.54 Million CNY | -30.67% |
| 2013 FY | 81.92 Million CNY | -2.8% |
| 2013 Q1 | 27.76 Million CNY | 178.71% |
| 2012 Q2 | 14.92 Million CNY | -53.5% |
| 2012 Q1 | 32.09 Million CNY | 88.78% |
| 2012 FY | 84.28 Million CNY | -28.97% |
| 2012 Q4 | 9.96 Million CNY | -63.53% |
| 2012 Q3 | 27.31 Million CNY | 83.03% |
| 2011 Q4 | 16.99 Million CNY | -61.0% |
| 2011 FY | 118.66 Million CNY | 13.09% |
| 2011 Q1 | 24.17 Million CNY | -10.84% |
| 2011 Q2 | 33.9 Million CNY | 40.22% |
| 2011 Q3 | 43.58 Million CNY | 28.55% |
| 2010 Q4 | 27.11 Million CNY | -27.49% |
| 2010 FY | 104.92 Million CNY | 27.45% |
| 2010 Q1 | 11.5 Million CNY | -61.33% |
| 2010 Q2 | 28.89 Million CNY | 151.15% |
| 2010 Q3 | 37.4 Million CNY | 29.42% |
| 2009 FY | 82.32 Million CNY | 11.94% |
| 2009 Q4 | 29.75 Million CNY | 35.8% |
| 2009 Q3 | 21.91 Million CNY | 0.0% |
| 2008 FY | 73.54 Million CNY | 30.47% |
| 2007 FY | 56.37 Million CNY | 0.0% |